% | $
Quotes you view appear here for quick access.

St. Jude Medical Inc. Message Board

  • eightironfrom160 eightironfrom160 Mar 23, 2000 5:30 PM Flag


    appears you know what the hell your talking
    about--appreciate that give the bs I see on most boards--I come
    from pharma so i don't know jack about devices other
    than the life cycles are more like chips than

    in long on stj per a newsletter reco--where's this

    ps have a very good friend at GDT--he's richer than
    dirt off his options and 5 yrs my jr--right place,
    right time....they seem to be kicking ass?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • lol thats a good 1 naw i dont own any but sounds as if youve been here a while though.
      ha! good luck to u BUDDDDDDD!!!!!!

    • something up between BSX and STJ ?
      With ABT as the center ???
      Anone with any further Info ???

    • Remember the Scimed days when Angioplasty was
      just starting,remember the performance of Scimed stock
      back then, well, STJ will create a new industry in the
      By Pass Surgery arena. With the advent of minimally
      invasive cardiac surgery this new product will allow most
      surgeons to perform this proceadure on a beating heart
      with high precision and in record time, STJ has the
      best sales force in the cardiac surgery industry, they
      will make this product a success,they will bring this
      to market in record time and capture the lions share
      for this type of devices. The CRMD division is full
      steam ahead capturing significant market share from
      both GDT and MDT,with the new Photon dual chamber ICD
      and all the CHF applications in clinicals, well, the
      story is just begining. STJ longs will be rewarded.

    • I'm in on the same newsletter reco as you, I
      imagine. I've done a fair amount of DD on this one and see
      little to no downside. It's a value play with a growth
      profile, significant discount to peers, solid performance
      several quarters running, and with even a little respect
      from the sell side has an easy shot at 50% ROI from
      here. GDT has had a great run and has definitely kicked
      ass in a few key segments. However look at their 10-K
      closely and see the cracks forming--- legal issues in
      particular. Also year over year performance comps are gonna
      be real hard from here on out. I question the
      multiple on this one for sure. IMHO. BTW, takes me at
      least a hard 7 to do 160.

78.01+0.19(+0.24%)Aug 26 4:01 PMEDT